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Abstract: 
 
Background: Metabolic syndromes are the multi-metabolic abnormality characterized by 
hyperlipidemia, obesity, hyperglycemia, diabetes, hypertension, cardiovascular disease, and 
neuro-dysfunction. Naringenin, a naturally occurring flavanone compound, abundantly found in 
citrus fruit, has demonstrated diverse biological activities. In this context, the role of naringenin 
in the treatment of metabolic disease and alternative sources for high-yield production of 
naringenin have recently drawn full scientific attention and become an important issue in 
research. Scope and approach: This review focuses on recent findings of naringenin against 
metabolic disorders including oxidative stress, hyperlipidemia, obesity, diabetes, inflammation, 
and organ toxicity. Also, this review highlights the potential sources of naringenin production. 
Key findings and conclusions: Naringenin exerts its protective effect against metabolic diseases 
through multiple mechanisms including its antioxidant activity by scavenging free radicals, 
inducing antioxidant enzymes and targeting on phosphoinositide 3-kinase/protein Kinase 
B/nuclear factor (erythroid-derived 2)-like 2 (PI3K/Akt/Nrf2), nuclear factor (erythroid-derived 
2)-like 2/antioxidant responsive element (NRf2/ARE), nuclear factor kappa-light-chain-enhancer 
of activated B cells (NF-kB), mitogen-activated protein kinase (MAPK), 3-hydroxy-3-methyl-
glutaryl-coenzyme A (HMG-CoA) reductase, peroxisome proliferator-activated 
receptor (PPAR), and nitric oxide-cGMP-protein kinase G-induced KATP channel (NO-cGMP-
PKG-KATP). Moreover, microbial production is recommended as a promising alternative method 
for large-scale production of naringenin. In conclusion, naringenin is a promising compound for 
the prevention and management of metabolic diseases. Further clinical studies and trials are 
needed to prove its protective effects on metabolic syndrome in the human population. 
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Article: 
 
1. Introduction 
 
Metabolic syndromes (MetS) are characterized by a cluster of metabolic abnormalities, such as 
high blood pressure, hyperglycemia, central adiposity, dyslipidemia, and increase the risk of 
cardiovascular disease, stroke, and type II diabetes (Kaur, 2014). Over the past decades, MetS 
has become a major public health issue as well as a clinical challenge for the world and its global 
prevalence ranges from 10 to 84%, based on lifestyle, environmental, physiological, 
biochemical, clinical and metabolic factors (Song, Yu, Chang, Wang, & An, 2017). According to 
National Cholesterol Education Program-Adult Treatment Panel III (NCEP-ATPIII, governed by 
the National Institutes of Health, United States) guidelines, the overall MetS prevalence in US 
adults increased from 22 to 34% in the years of 2000–2005 (Beltran-Sanchez, Harhay, Harhay, 
& McElligott, 2013; Mozumdar & Liguori, 2011); while in Chinese adults, the prevalence was 
21.3% in 2009 (Xi, He, Hu, & Zhou, 2013). A recent cohort study on MetS found that childhood 
MetS and obesity from five years are correlated with approximately 2.4-fold higher risk for 
adulthood MetS, thereby childhood MetS and overweight have been suggested to be a significant 
predictor for adulthood MetS (Koskinen et al., 2017). MetS prevalence was shown in upward 
trends not only in China but also in other Asia Pacific countries. Their study also revealed that 
females and/with urban residents have the highest MetS prevalence (Ranasinghe, 
Mathangasinghe, Jayawardena, Hills, & Misra, 2017). For the prevention and cure from major 
risk factors of MetS, people used various chemical and drug agents, such as Angiotensin-
Converting-Enzyme (ACE) inhibitors (Hypertension), Non-Sulfonylurea (Diabetes), and Statin-
lipid lowering agent (Hypercholesterolemia). Almost all the drugs produce some noticeable side-
effects, such as headache, dizziness, nausea, vomiting, rash, abdominal pain, liver disease, 
kidney disease, muscle weakness, and lactate acidosis etc. (Aksay, Yanturali, BAYRAM, 
Hocaoğlu, & Kiyan, 2007; Camerino et al., 2017; Palmer, 2004). 
 
Several studies proved the inverse association between dietary polyphenols intake and MetS 
using body weight, blood pressure, blood glucose, insulin resistance, cholesterol, oxidative 
stress markers, and inflammatory markers etc. (Chiva-Blanch & Badimon, 2017; Micek et al., 
2017; Su, Feng, Zheng, & Chen, 2016; Wu, Tang et al., 2014). Plant-derived polyphenols such 
as phenolic acids, curcuminoids, stilbenes, lignans, flavonoids, flavonols, flavones, 
anthocyanins, and others possess potential antioxidant, anti-inflammatory, anti-hypertensive, 
hepato-protective, cardio-protective, anti-diabetes, and anti-obesity activities (Ayoub et al., 
2017; Bao et al., 2016; Chen, Feng et al., 2013; Chen, Shen, Su, & Zheng, 2014; Hu et al., 
2018; Issa & Hussen Bule, 2015; Van Hul et al., 2017). An Italian population-based research 
found that high polyphenols intake reduced the mortality rate by about 30% in older adult 
subjects (Zamora-Ros et al., 2013) suggesting beneficial effects of polyphenols on ameliorating 
aging and mortality. The polyphenol intakes of Malaysian and Japanese people are 1218–4323 
and 827–2157 mg/day respectively, while the Brazilian people's intake polyphenol is only 451–
461 mg/day (Niyogi, 2016). This country-wide variation of polyphenol consumption may depend 
on plant source, food source, food habit (vegetarian or non-vegetarian), food processing, and 
others. Among the dietary polyphenols in plants, the highest proportion is flavonoids for 
approximately 67% (Martin & Appel, 2010). 
 
In this review, we provide the current developments on using naringenin against MetS and its 
associated diseases. We first discuss the characteristics of naringenin including its structural 
analysis and pharmacokinetics along with its metabolites. We then focus on recent findings 
related to the protective effects of naringenin against MetS and its associated diseases. 
Traditional extraction and purification methods of naringenin synthesis from natural sources are 
limited by high cost, low yield and are also time-consuming. Naringenin production in 
microorganisms is thus recommended as one of the alternative method to achieve high yield with 
low cost. 
 
2. Naringenin 
 
Naringenin (2,3-dihydro-5,7-dihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one) is a bitter 
and colorless compound abundant in citrus fruit, such as lemon, orange, clementine, and 
grapefruit (Al-Dosari, Ahmed, Al-Rejaie, Alhomida, & Ola, 2017; Erlund, 2004; Esaki et al., 
1994). Grapefruit jams obtained by applying different types of heat treatment (e.g., osmotic 
dehydration, microwave energy, and conventional heating) significantly decreased the fruit 
phytochemicals (β-carotene and flavonoids) content. Based on their study, the total loss of β-
carotene and flavonoids in jams was approximately 53–86% and 33–47%, respectively. It 
indicates that fruit processing may also affect the naringenin content by degrading the heat-
sensitive compound and releasing the bound flavanone to processing environment (Igual, Garcia-
Martinez, Camacho, & Martínez-Navarrete, 2013). Naringenin is readily soluble in the binary 
solution of ethanol and water (Zhang et al., 2013). Naringenin has the typical structure of a 
flavanone that contains hydroxyl groups (at 5, 7 and 4′ positions). These hydroxyl groups can be 
substituted by different functional groups to produce structural analogs (Fig. 1) (Erlund, 2004; 
Krauze-Baranowska et al., 2013). Naringenin has a single chiral center at the C-2 position, which 
is responsible for its enantiomeric properties (Fig. 1) (Yanez, Andrews, & Davies, 2007). 
 
 
Fig. 1. Structure of naringenin and its analogs. 
 
Several structural analogs of naringenin have been identified from citrus fruit such as naringenin-
7-glucoside. Compared to naringenin-7-rhamnoglucoside, naringenin-7-glucoside has exhibited 
well intestinal absorption (Bredsdorff et al., 2010; Felgines et al., 2000). 4′-O-methyl naringenin 
and 3′-hydroxy-4′-O-methylnaringenin are two metabolites of naringenin known as 
isosakuranetin and hesperetin, respectively. Both metabolites were detected in lower amounts 
(approximately 2% of the total plasma flavanones) in rat plasma after consuming the synthetic 
diet containing 0.5% naringin, a naringenin-7-O-neohesperidoside compound containing two 
rhamnose units at 7′ position of naringenin, for seven days (Silberberg et al., 2006). Sakuranetin 
(7-O-methylnaringenin) is obtained from rice and Polymnia fruticosa. This compound can also 
be synthesized from naringenin by naringenin-7-O-methyltransferase (Shimizu et al., 2012). 
Aromadedrin or dihydrokaempferol is a flavanonol, which is synthesized from naringenin by 
transferring the plant-derived flavanone-3-hydroxylase enzyme into Escherichia coli (Han et al., 
2017; Tu et al., 2016). β-Glucosidases produced from Rhizopus azygosporus Yuan et Jong (a 
food-grade fungal inoculator for soybean tempeh fermentation) can convert naringenin into 
eriodictyol sulfate and eriodictyol glucoside within 96 h in culture medium (Gonzales et al., 
2016). 
 
To date, a limited number of pharmacokinetics studies of naringenin has been published. After 
the consumption of flavanone glycosides (e.g., naringin), these compounds reach the colon and 
get hydrolyzed into aglycones (e.g., naringenin) by microflora. These flavanone aglycones are 
partially absorbed in the intestinal barrier (Felgines et al., 2000; Manach, Morand, Gil-Izquierdo, 
Bouteloup-Demange, & Remesy, 2003). Partial absorption of flavanone aglycones and 
glucosides can occur through passive diffusion across the small intestine (Choudhury, 
Chowrimootoo, Srai, Debnam, & Rice-Evans, 1999; Felgines et al., 2000; Serra, Mendes, 
Bronze, & Simplício, 2008). Several studies explained that flavanones can be metabolized in the 
intestinal and hepatic cells, and are then converted into glucuronic-/sulfo-conjugated derivatives 
prior to excretion (Bourian et al., 1999; Fuhr & Kummert, 1995; Ishii, Furuta, & Kasuya, 1997; 
Lee & Reidenberg, 1998; Lin, Hou, Tsai, Wang, & Chao, 2014; Wang, Chao, Hou, & Hsiu, 
2006). 10 min after naringenin administration (20 mg/kg) to rats, naringenin and its glucuronides 
were detected in concentrations four times higher in the plasma than in the brain tissue (Peng, 
Cheng, Huang, Chen, & Tsai, 1998). In another extended study using microdialysis coupled with 
HPLC analysis, higher concentrations of naringenin were detected in liver and bile compared to 
the brain in rats (Tsai, 2002). Plasma concentration and urinary excretion of naringenin 
(estimated by HPLC analysis) can be considered as biomarkers for fruit and vegetable intake 
(Brevik, Rasmussen, Drevon, & Andersen, 2004; Erlund et al., 2002; Mennen et al., 2008). 
 
There are a few reported clinical trials about naringenin on MetS. In a recent study on male 
endurance athletes, the bioavailability of orange juice was assessed by the quantitative analysis 
of urinary flavanone metabolites. The results showed that after consumption of 500 ml of orange 
juice, the total naringenin metabolites reached 76 μM in the urine sample of male endurance 
athletes (Pereira-Caro et al., 2017). In another trial, after consumption of 250 ml orange juice in 
Chinese volunteers (23–30 years), the total naringenin in urine reached approximately 22% of 
intake content within 4–12 h as measured by an ultra-fast liquid chromatography-quadrupole-
time-of-flight tandem mass spectrometer (Zeng et al., 2017). Intake of 240 ml orange flavanone 
beverages (containing 15.41 mg naringenin) in healthy middle-aged men (30–65 years) 
significantly (P < 0·05) reduced the postprandial endothelial dysfunction as evaluated by flow-
mediated dilatation (FMD) of the brachial artery at 0–7 h (Rendeiro et al., 2016). Six-months 
consumption of grapefruit juice (340 ml/day, containing 210 mg naringenin glycosides) 
significantly improved the vascular endothelial function in postmenopausal women (Habauzit et 
al., 2015). 
 
Several studies demonstrated that naringenin possessed different biological activities (Fig. 2). 
These include antidiabetic activity by reducing hepatic and pancreatic inflammation (Annadurai, 
Thomas, & Geraldine, 2013); an anti-metastatic effect by enhancing transglutaminase activity 
and polyamine depletion (Lentini, Forni, Provenzano, & Beninati, 2007); cytotoxic activity by 
inhibiting lung large cell carcinoma (COR-L23), amelanotic melanoma (C32), prostate 
adenocarcinoma cells (LNCaP) and human cancer cell proliferation (Tundis, Loizzo, Menichini, 
Bonesi, & Colica, 2011); neuroprotective effects against colchicine-induced cognitive 
dysfunction (Kumar, Dogra, & Prakash, 2010); renoprotective effects against cadmium (Cd)-
induced renal dysfunction (Renugadevi & Prabu, 2009); anti-ulcerative effect by inhibiting 
histidine decarboxylase (Parmar, 1983); anti-inflammatory activity by suppressing Toll-like 
receptor 4/NF-κB signaling (Dou et al., 2013); anti-photocarcinogenic activity by stimulating 
melanogenesis (Chiang, Lin, Hsiao, Tsai, & Wen, 2011); and anti-bacterial activity by 
inhibiting Salmonella thypi in comparison with chloramphenicol (Agus, Achmadi, & Mubarik, 
2017). 
 
 
Fig. 2. Biological effects of naringenin. 
 
3. Antioxidant and free radical scavenging activity of naringenin 
 
Oxidative stress is caused by an imbalance between oxidants and antioxidants. Overproduction 
of free radicals and peroxides can damage cell components such as lipid, protein, and DNA, etc. 
(Chen, Zhuang, Li, Shen, & Zheng, 2013; Zhang et al., 2017; Zhang, Liu, et al., 2017; Li, Bao, & 
Chen, 2018). Naringenin can potentially protect from oxidative damage via scavenging free 
radicals (Table 1). 
 
Table 1. Antioxidant, Anti-hyperlipidemic and Anti-obesity effect of Naringenin. 
Antioxidant and free radical scavenging activity 
Source Compound/Extract and dose Model (in vitro/in vivo) Research Outcome Significance 
Zea mays Methanol (80): water (20) extract. 
Dose- 100 mg/mL (contain 
naringenin- 148 mg/kg sample) 
Albino male mice • Reduced the MDA level and improved the endogenous 
antioxidant enzyme (CAT, TPX, and SOD). 
Antioxidant activity 
(Ramos-Escudero et al., 
2012). 
Xi'an Xiao Cao 
Botanical 
Development 
Co., Ltd 
Naringenin - (50 mg/kg) Lead (Pb)-induced adult male 
rats 
• Improved the biochemical parameters, oxidative stress and 
antioxidant enzyme (MDA, CAT, SOD, GSH, and GPX). 
Xeno-protective effect 
(Wang et al., 2012). 
Sigma-Aldrich Naringenin - (20 or 50 mg/kg) Arsenic (As)-induced adult 
male rats 
• Improved the serum biomarkers and tissues oxidative 
stress/antioxidant enzymes in a dose-dependent manner and 
restored the tissues histology. 
Xeno-protective effect 
(Mershiba et al., 2013). 
Sigma-Aldrich Naringenin - (5 or 10 mg/kg) Arsenic (AS)-induced swiss 
albino mice 
• Significantly normalized the body weights, organ weights, 
hematological and serum biochemical profile, tissues oxidative 
stress/antioxidant parameters, and DNA fragmentation. 
Xeno-protective effect (Roy 
et al., 2014). 
Citrus aurantium 
L. 
Ethanolic extract - 100 and 
300 mg/kg (contain naringenin) 
Chromium (VI)-induced 
female Wistar rats 
• Alleviated the oxidative stress/antioxidant enzyme profile of lung 
tissue and reformed the tissue histology. 
Xeno-protective effect 
(Soudani et al., 2013). 
Sigma-Aldrich Naringenin (4 and 8 mg/kg) Cadmium (Cd)-induced swiss 
albino mice 
• Significantly improved the body weights, organ weights, 
hematological and serum biochemical profile, tissue oxidative 
stress/antioxidant parameters. 
Xeno-protective effect (Das 
et al., 2016) 
Solanum 
lycopersicum 
Naringenin (10 μM) UV light-induced human 
dermal fibroblasts (CCD-
1064Sk) cell line 
• Reduced the ROS formation, increased cell viability, carotenoid 
stability, and HO-1 expression. 
Photo-protective effect 
(Fernandez-Garcia, 2014) 
Santa Cruz 
Biotechnology 
Naringenin (20, 30, 100 mg/kg) UVB irradiation-induced 
hairless mice 
• Inhibited the skin edema, neutrophil recruitment, MMP-9 
activity, pro-/anti-inflammatory cytokines, and oxidative stress 
markers (O2•− production and gp91phox expression). 
Photo-protective and anti-
inflammatory effect 
(Martinez et al., 2015). 
Sigma-Aldrich Naringenin (100 mg/kg) Retinoic acid-induced bone 
loss rats 
• Improved the bone weight coefficient, bone length and diameter, 
bone ash content, bone calcium and phosphorus content. 
Anti-osteoporosis effect 
(Orsolic et al., 2014). 
Sigma-Aldrich Naringenin (50 mg/kg) Doxorubicin-induced dalton's 
lymphoma ascites (DLA) 
tumor-bearing mouse 
• Improved the blood functional markers, tissues antioxidant 
enzymes, histopathological changes, and tumor 
microenvironment. 
Chemoprotective effect 
(Kathiresan et al., 2016). 
 
Naringenin-Oxime (20 and 
40 mg/kg) 
Cisplatin-induced Wistar 
albino rats 
• Restored the biochemical parameters, oxidative 
stress/antioxidant profile of serum and tissues; and reduced the 
DNA damage markers (8-OHdG level, comet formation). 
Chemoprotective effect 
(Koyuncu et al., 2017). 
Sigma-Aldrich Naringenin - (50 mg/kg) Gentamycin-induced adult 
male rats 
• Enhanced the audiological measurement (DPOAE and ABR), 
antioxidant and biochemical profiles, and cochleae histological. 
Anti-ototoxicity effect 
(Kocak et al., 2017). 
Sigma-Aldrich Naringenin (100 mg/kg) Benzo [a]pyrene-induced 
male Wistar rats 
• Reduced the oxidative stress markers, inflammatory markers, 
NF-kB and COX-2 expression. 
• Improved the antioxidant enzymes activity and lung histological. 
Antioxidant and anti-
inflammatory effect (Ali et 
al., 2017).  
Naringenin (50 mg/kg) H2O2-induced male Wistar 
rats 
• Improved the testis weight, oxidative stress/antioxidant markers 
(MDA, GSH, GST), and testis histology. 
Antioxidant activity (Sahin 
et al., 2017). 
Sigma-Aldrich Naringenin (5–100 μM) Paraquat-induced human 
bronchial epithelial (BEAS-
2B) cell line 
• Reduced the intracellular ROS production, upregulated the 
antioxidant-related genes expression, induced the NRF2 
expression and its target genes (HO-1 and NQO1). 
Cytoprotective effect 
(Podder et al., 2014) 
 
Naringenin (0.30 mM) Sodium tungstate-exposed 
male Wistar rats 
• Improved the blood δ-aminolevulinic acid dehydratase (ALAD) 
activity, oxidative stress and antioxidant markers (blood, liver 
and spleen tissue). 
Xeno-protective effect 
(Sachdeva & Flora, 2014) 
Anti-hyperlipidemic and anti-obesity effect 
Sigma-Aldrich Experimental diet (naringenin - 
0.1%) 
Male Sprague-Dawley rats • Decreased the plasma and hepatic cholesterol content, fecal 
neutral sterols, and inhibited the HMG-CoA reductase and 
ACAT activities. 
Hypolipidemic effect (Lee et 
al., 1999). 
 
Naringenin (1 and 3%) High fat fed –induced LDL 
receptor null (Ldr (−/−)) 
and C57BL/6J mice 
• Improved the hepatic fatty acid oxidation, insulin sensitivity, and 
glucose tolerance. Decreased the hepatic cholesterol, cholesterol 
ester synthesis, VLDL derived and endogenous fatty acids. 
Hypolipidemic effect 
(Mulvihill et al., 2009) 
Sigma-Aldrich Naringenin - 3% High-/low-cholesterol-
induced male (Ldr (−/−)) 
mice 
• Improved dyslipidemia, insulin resistance, inflammation 
associated with obesity and atherosclerosis disease. 
Anti-hyperlipidemic and 
anti-inflammatory activity 
(Assini et al., 2013).  
Naringenin doses - 0.003, 0.006, 
and 0.012% in experimental 
diet. 
High fat diet-induced male 
long-evans hooded rats 
• Reduced the plasma, liver, and adipose tissue lipid profile, 
• Upregulated the fatty acid oxidation-related genes expression 
(PPAR-α, CPT-1 and UCP2). 
Hypolipidemic and anti-
adiposity effects (Cho et 
al., 2011).  
Naringenin (10 mg/kg) High fat diet-induced obese 
mice 
• Improved the serum and hepatic lipid metabolism, lipolysis and 
lipogenesis-related gene expression. 
Anti-obesity effect (Zar 
Kalai et al., 2013). 
Sigma-Aldrich Naringenin (6–50 g/mL) 3T3-L1 cell line • Decreased the lipid accumulation, and protein expression of 
adipocyte (aP2, ADPN, PPAR, STAT5A). 
Anti-adipogenic effect 
(Richard et al., 2013). 
 
Table 2. Antidiabetic and Anti-inflammatory effect of Naringenin. 
Anti-hyperglycemic and antidiabetic effect 
Source Compound/Extract and dose Model (in vitro/in vivo) Research Outcome Significance 
Acalypha 
wilkesiana 
Aqueous extract, doses-100, 
200 and 300 mg/kg 
(naringenin-11.12%) 
Alloxan-induced 
diabetic rats 
• Reduced the hyperglycemia and ocular oxidative stress markers. 
• Improved the lipid profile, hepato-specific profile, electrolyte profile, 
atherogenic index, and hematological markers. 
Retino-/Cardio-protective 
effects (Ikewuchi et al., 
2011). 
Sigma-Aldrich Naringenin (50 mg/kg) Alloxan-induced 
diabetic mice 
• Improved the body weight, blood hematological and immunological 
parameters, and peripheral lymphocytes DNA damage. 
Anti-genotoxic effect (Orsolic 
et al., 2011). 
 
Naringenin (5 μg) Glucose-induced 
primary hepatocyte 
(Rats) 
• Improved the cell viability, intracellular antioxidant profile. 
• Reduced the ROS generation, Cyt-c and AIF/Endo-G translocation, 
caspase-9/-3 activation, Bcl-2 family genes expression, DNA damage 
and chromatin condensation. 
Anti-apoptosis effect (Kapoor 
et al., 2013). 
Sigma-Aldrich Naringenin (50 mg/kg) Streptozotocin-induced 
diabetes rats 
• Alleviated the ROS generation, oxidative stress parameters, liver and 
kidney biomarkers, mitochondrial membrane dysfunction, and 
apoptotic proteins expression of liver tissue. 
Anti-apoptosis effect (Kapoor 
& Kakkar, 2014). 
Sigma-Aldrich naringenin (5 and 10 mg/kg) Streptozotocin-induced 
diabetes rats 
• Reduced the biochemical and oxidative stress parameters, renal 
degradation, TGF-β1 and IL-1 upregulation, and kidney apoptosis. 
Nephroprotective effect (Roy et 
al., 2016). 
Sigma-Aldrich Naringenin (50 mg/kg) Alloxan-induced 
diabetic mice 
• Restore the diabetics induced the hepatic and renal pathological 
changes. 
Hepato-/reno-protective effect 
(Sirovina, Oršolić, 
Gregorović, & Končić, 2016) 
Sigma-Aldrich Naringenin (50 mg/kg) Streptozotocin–
nicotinamide-induced 
diabetic rats 
• Significantly lowered the blood glucose and glycosylated hemoglobin; 
improved the serum insulin, plasma, and pancreatic tissue antioxidants 
enzyme; restore the pancreatic histology. 
Anti-hyperglycemic and 
antioxidant activity 
(Annadurai et al., 2012). 
SRL, India Naringenin (25, 50 mg/kg) High-fat diet/high fat 
emulsion with 
streptozotocin-
induced T2D rats 
• Improved the body weight and blood glucose, MDA, nitric oxide and 
reduced glutathione levels. 
• Reduced the locomotor activity and inhibited the cholinesterase 
activity. 
Neuro-protective effect 
(Rahigude et al., 2012). 
Sigma-Aldrich Naringenin (25 and 50 mg/kg) Streptozotocin-induced 
diabetic rats 
• Lessened the serum glucose, pro-inflammatory cytokines, nitric oxide 
production, oxidative stress marker (MDA); improved the insulin 
levels, antioxidant enzyme activity, insulin growth factor (IGF) and 
nerve growth factor (NGF) expression of the sciatic nerve, and sciatic 
nerve histology. 
Neuro-protective effects (Al-
Rejaie et al., 2015). 
 
Naringenin (50 mg/kg) Streptozotocin-induced 
diabetic rats 
• Ameliorated the hyperglycemia, oxidative stress/antioxidant markers, 
apoptosis markers (Bax/Bcl2, caspase-3), and neuroprotective factors 
(Brain-derived neurotrophic factor, tropomyosin-related kinase B, and 
synaptophysin). 
Retino-protective effect (Al-
Dosari et al., 2017). 
 
Naringenin (50 or 100 mg/kg) High-fat diet 
/streptozotocin-
induced diabetic rats 
• Ameliorated the glucose and lipid metabolism, insulin resistance, 
oxidative stress and inflammation markers, and thoracic aorta's 
pathology. 
Anti-vasculopathy effect (Ren, 
et al., 2016). 
Cola nitida Naringenin content- 3.6% In-vitro • Inhibited the α-amylase and α-glucosidase enzyme activity and reduced 
the pancreatic MDA level. 
In-vitro anti-diabetic activity 
(Oboh et al., 2014).  
Naringenin (50 mg/kg) Pancreatic endoderm 
derived from human 
embryonic stem cells 
(hESCs) 
• Improved the body weight, blood glucose, and insulin level, oxidative 
stress/antioxidant markers, reproductive outcome. 
Anti-diabetic activity (Xing et 
al., 2016). 
Anti-inflammatory effect 
 
Naringenin (25, 50, and 
100 mg/kg) 
Acetic acid-induced rats • Significantly reduced the colon weight/length, colon histological 
changes, oxidative stress, inflammatory protein; increased the mucosal 
content, antioxidant profile (T-GSH, NPSH, SOD, CAT), nucleic acids 
concentrations (DNA, RNA, total protein). 
Antioxidant and anti-
inflammatory effects (Al-
Rejaie et al., 2013). 
Sigma-Aldrich Naringenin (50 mg/kg) High-cholesterol fed 
rats 
• Improved the hematological parameters, lipid profile, renal oxidative 
stress-related markers, renal histology, mRNA expression of kidney 
and platelets membrane (Ecto-nucleotide triphosphate 
diphosphohydrolases (NTPDases), ecto-5′-nucleotidase (CD73), iNOS, 
TNF-α, IL-6, and NF-κB). 
Anti-inflammatory and anti-
aggregate activity (Chtourou 
et al., 2016). 
Sigma-Aldrich Naringenin (50 and 
100 mg/kg) 
Lipopolysaccharide 
(LPS)-induced rats 
• Reduced the wet/dry lung weight ratio, tissue biochemical profile 
(MDA, NO, IL-6, MPO), lung histological damage, lung immune-
histochemical expression (NF-κB, iNOS, TNF-α, caspase-3, and 
HSP70). 
Antioxidant, Anti-
inflammatory, anti-
nitrosative, and anti-apoptotic 
effect (Fouad et al., 2016). 
Santa 
Cruz 
Biotechnology 
Naringenin (16.7, 50, and 
150 mg/kg) 
Superoxide anion 
(KO2)-induced mice 
• Reduced the pain like behavior, mechanical hyperalgesia, thermal 
hyperalgesia, MPO activity, oxidative stress-related markers, and 
cytokine production (IL-33, IL-10, and TNF- α); and activated the NO-
cGMP-PKG-KATP channel and related Nrf2/HO-1 signaling pathway. 
Anti-nociceptive, anti-
inflammatory effect 
(Manchope et al., 2016). 
 
Naringenin (50 mg/kg) Lipopolysaccharide 
(LPS)- induced mice 
• Reduced the pain like behavior, mechanical hyperalgesia, thermal 
hyperalgesia, MPO activity, oxidative stress-related markers, and 
cytokine production in the paw skin. Naringenin also the reduced 
leukocyte recruitment, MPO and NAG activity, cytokine and 
superoxide anion production, and LPO in the peritoneal cavity. 
Anti-nociceptive, anti-
inflammatory effect (Pinho-
Ribeiro et al., 2016a). 
 
Naringenin (50 mg/kg) Indomethacin-induced 
mice 
• Inhibited the oxidative stress, NF-kB activation, hyperalgesic cytokine 
production, neutrophil recruitment, and NO-cyclic GMP-PKG-ATP 
sensitive K+ channel pathway activation. 
Anti-nociceptive, anti-
inflammatory effect (Pinho-
Ribeiro et al., 2016b). 
Santa Naringenin (0.5%) Ultraviolet B 
irradiation- 
• Reduced the skin edema, superoxide anion and lipid hydroperoxides 
production, inflammatory cytokines (TNF-α, IL- 
Anti-inflammatory and anti- 
Cruz 
Biotechnology 
 
induced hairless mice 1β, IL-6, and IL-10). Improved the mRNA expression of GPx-1, GR, 
Nrf2, and HO-1. 
oxidative stress activity 
(Martinez et al., 2016). 
Sigma-Aldrich Naringenin (25, 50, and 
100 mg/kg) 
Thermal burn-induced 
rats 
• Reduced the pro-inflammatory cytokines (TNF- α, IL-1 β, IL-6), 
inflammatory markers (NO, PGE2, Caspase-3, LT-B4, and NF-kB), 
oxidative stress parameters, and dermal histological changes. 
Anti-inflammatory and 
antioxidant effects (Al-
Roujayee, 2017).  
Naringenin (50, 100 or 
200 μM) 
Pemphigus vulgaris-
treated HaCaT cell 
line 
• Improved the cellular apoptosis, antioxidant activity, cell-cell contacts 
disruption (cell fragments), ROS generation and mitochondrial 
transmembrane potential, keratinocyte adhesion molecules (Dsg1, 
Dsg3, and E-cadherin) and NOD2- mediated NF-kB pathway 
expression (NOD2, RIPK2, and NF-kB p-p65). 
Antioxidant, anti-inflammatory 
and anti-apoptosis effects 
(Liang et al., 2017). 
As one of the xenobiotic metals, lead (Pb) can be detectable in all biological systems. Exposure 
to lead (Pb) also causes cellular oxidative damage of various vital organs, such as liver, kidney, 
heart, and others. Naringenin was reported to protect significantly (P < 0.05) against lead (Pb)-
induced oxidative stress compared to control group as evaluated by biochemical, oxidative stress, 
and antioxidative markers in the serum, liver, and kidney (Wang et al., 2012). Mershiba, 
Dassprakash, and Saraswathy (2013) reported that treatment of naringenin (20 or 50 mg/kg/day) 
for 28 days significantly protects against arsenic (As)-induced oxidative damage in rat liver and 
kidney via exerting antioxidant effects and radical quenching action. Naringenin treatments also 
significantly improved the serum and antioxidant enzymes biomarkers in a dose-dependent 
manner; and restored the tissues pathological changes (Mershiba et al., 2013). Another study also 
revealed the protective effect of naringenin (5 or 10 mg/kg/day) against arsenic (As)-induced 
oxidative damage in mice model (Roy et al., 2014). On the other hand, the ethanol extract 
of Citrus aurantium L. at doses of 100 and 300 mg/kg/day (naringenin as the main component of 
citrus fruit) showed the anti-oxidative effects against chromium (VI)-induced lung dysfunction. 
The extract significantly alleviated the oxidative stress (MDA and protein carbonyl levels) and 
antioxidant (GSH, sulfhydryl groups, NPSH, vitamin C, vitamin E, Na+ K+ ATPase, CAT, GPx, 
and SOD) profile of lung tissue, and reformed the tissue histology (Soudani et al., 2013). 
Naringenin alleviates the cadmium (Cd)-induced hepatic and renal toxicity in mice (Das, Roy, 
Das, Bhattacharya, & Haldar, 2016). Tungsten (W) is a heavy metal and has been widely used in 
various household products and instruments. Human beings can also easily be exposed to this 
metal by the environment. Treatment with naringenin was found to attenuate the oxidative stress 
and antioxidant markers of blood, liver, and spleen in rats exposed to sodium tungstate (3 
months, 100 ppm in drinking water) (Sachdeva & Flora, 2014). Naringenin reduced the sodium 
tungstate-induced oxidative stress through exerting metal chelating activity. 
 
Methanol: water (80:20) extract of Zea mays (naringenin-148 mg/kg) exhibited in vitro 
antioxidant activity. Mice treated with such extracts also showed reduced malondialdehyde 
(MDA) levels and improved endogenous enzymes activities (Catalase (CAT), total peroxidase 
(TPX), superoxide dismutase (SOD)) in the liver, kidney, and brain (Ramos-Escudero, Muñoz, 
Alvarado-Ortíz, Alvarado, & Yánez, 2012). It is recommended to isolate the naringenin 
compound from purple corn extracts to evaluate the specific antioxidant properties. Advanced 
glycation endproducts (AGEs) produces the cellular oxidative damage and plays causative roles 
in the development of different chronic diseases. Naringenin exerted anti-glycation activity by 
inhibiting total fluorescent AGEs and non-fluorescent carboxymethyl lysine (CML) formation 
(Zhang, Hu, Chen, & Wang, 2014). As a result, naringenin can reduce the thermal protein 
glycation, which could be a promising way to alleviate the oxidative stress. 
 
UV light exposure to the skin causes aging or photocarcinogenesis by the formation of reactive 
oxygen species (ROS) known as photooxidative stress. Solanum lycopersicum (tomato) 
contains lycopene, alpha-tocopherol, naringenin and other compounds. Co-incubation of 
lycopene (1 μM) and naringenin (10 μM) exhibited a protective effect against UV light-induced 
human dermal fibroblasts cell (HDF) oxidative damage. It was evaluated by a decrease in ROS 
formation and an increase in cell viability, carotenoid stability, and HO-1 expression (Fernandez-
Garcia, 2014). It is indicated that naringenin could prevent oxidative degradation of carotenoids 
via inducing HO-1 expression. Also, treatment with naringenin (through intraperitoneal injection 
(i.p.), 20, 30, and 100 mg/kg) protected the hairless skin of mice from ultraviolet B (UVB) 
irradiation-induced inflammation and oxidative damage. This treatment suppressed skin edema, 
neutrophil recruitment, MMP-9 activity, pro-inflammatory cytokines, and oxidative stress 
markers (O2•− production and gp91phox expression) compared to a non-irradiated control group 
(Martinez et al., 2015). The compound reduced the skin-damage by enhancing free radicals 
scavenging activity, ameliorating endogenous antioxidants depletion, and inhibiting production 
of gp91phox-dependent O2•− and its derivatives. 
 
In a paraquat-induced human bronchial epithelial (BEAS-2B) cell model, naringenin (5–100 μM) 
showed a cytoprotective effect against paraquat-induced intracellular ROS production. 
Naringenin upregulated the antioxidant-related gene expression (GPX2, GPX3, GPX5, and 
GPX7), and activated expression of Nrf2 and its targeted gene (HO-1 and NQO1) (Podder, Song, 
& Kim, 2014). High dose of retinoic acid play an essential role in inducing osteoporosis through 
oxidative stress. Naringenin (100 mg/kg) treatment significantly alleviated the oxidative damage 
and bone mineral contents induced by retinoic acid (80 mg/kg) (Orsolic et al., 2014). In Dalton's 
Lymphoma Ascites (DLA) tumor-bearing mouse model, treatment with naringenin 
(50 mg/kg/day) significantly attenuated doxorubicin-induced toxicity and hypoxic condition. 
Here, the treatment improved the blood functional markers, antioxidant enzymes in tissues 
(kidney, heart, lung, liver, spleen, and tumor), histopathological changes, and tumor-
microenvironment as compared to a doxorubicin-treated group (Kathiresan et al., 2016). 
During doxorubicin chemotherapy, naringenin supplement prevented the doxorubicin-induced 
free radical generation and maintained antioxidant levels in the tumor-microenvironment. As a 
newly derived compound from naringenin, naringenin-oxime exhibited the greater anticancer 
potential than naringenin (Kocyigit, Koyuncu, Dikilitas, Bahadori, & Turkkan, 2016). Moreover, 
co-treatment with cisplatin (7 mg/kg) and naringenin-oxime (20 and 40 mg/kg) significantly 
reduced the cisplatin-induced adverse effects such as nephrotoxicity, neurotoxicity, 
hepatotoxicity, and genotoxicity. The co-treatment modulated the altered oxidative stress, 
antioxidant, genotoxic markers in serum and organs (Koyuncu, Kocyigit, Gonel, Arslan, & 
Durgun, 2017). Pretreatment of naringenin-oxime may protect from cisplatin-induced oxidative 
damage of DNA. Gentamicin is an aminoglycoside antibiotic against Gram-negative bacteria. 
However, it has potential side-effect, such as ototoxicity. Co-treatment with 120 mg/kg (i.p.) 
gentamicin and 50 mg/kg (p.o.) naringenin significantly minimized the gentamycin-induced 
ototoxicity compared to the group given gentamycin alone. The ototoxicity was assessed by 
distortion product otoacoustic emission (DPOAE) and auditory brainstem response (ABR) 
measurements, oxidative and antioxidant parameters, histology, and apoptosis (TUNEL assay) of 
cochleae (Kocak et al., 2017). Naringenin can suppress the gentamicin-induced ototoxicity via 
scavenging ROS, which are accumulated in the cochlea, and cause the cellular apoptosis and cell 
death. Benzo [a]pyrene is a potent mutagen and carcinogen from incompletely burned organic 
matters. Naringenin (100 mg/kg BW) enhanced the antioxidant and anti-inflammatory effects 
against benzo [a]pyrene-induced oxidative stress and pulmonary toxicity. The antioxidant and 
anti-inflammatory activity was determined by antioxidant enzyme activity markers, lung injury 
markers, lung histology, and inflammatory markers (NF-kB and COX-2) (Ali et al., 2017). Here, 
naringenin lowered the ROS-mediated oxidative damage and inflammation via exerting free 
radical scavenging activities and modulating NF-kB signaling pathway. In H2O2-induced 
testicular dysfunction rats, naringenin (50 mg/kg) significantly modulated the testis weight and 
oxidative stress/antioxidant markers (MDA, GSH, GST), when compared to a H2O2-treated 
control group. Naringenin supplement alleviates H2O2-induced seminiferous tubules 
disorganization, germ cells detachment from the seminiferous epithelium and basal membrane, 
sloughing of germ cells as well as vacuolization in seminiferous tubules in the testis. (Sahin, 
Ozkaya, Cuce, Uckun, & Yologlu, 2017). 
 
4. Anti-hyperlipidemic and anti-obesity effect of naringenin 
 
Hyperlipidemia is considered the prime symptom of obesity and associated metabolic diseases 
(Wu, Tang, et al., 2013; Wu, Yu, et al., 2013). Naringenin can effectively ameliorate the 
dyslipidemic condition and obesity of different biological models (Table 1). 3-Hydroxy-3-
methylglutaryl coenzyme A (HMG-CoA) reductase increases the intracellular cholesterol 
synthesis, whereas the Acyl-coenzyme A: cholesterol O-acyltransferase (ACAT) enzyme 
catalyzes the cholesterol esterification leading to atherosclerosis disease. Rats fed with 
experimental diet (containing 0.1% naringenin) for six months significantly lowered the plasma 
and hepatic cholesterol content, fecal neutral sterols, and inhibited the HMG-CoA reductase and 
ACAT activities when compared to a control group (received experimental diet without 
naringenin supplement) (Lee et al., 1999). Naringenin supplementation at 1% and 3% in a 
Western diet (high-fat diet) for 4 and 30 weeks respectively significantly alleviated dyslipidemia, 
insulin resistance, glucose intolerance, and obesity compared to the western diet fed groups in 
LDL receptor knockout (Ldr (−/−)) mice and C57BL/6J mice (Mulvihill et al., 2009). Moreover, a 
supplement of 3% naringenin in the diet to (Ldr (−/−)) mice significantly prevented cholesterol-
induced dyslipidemia, insulin resistance, inflammation associated with the obesity and 
atherosclerosis disease as compared to control groups (Assini et al., 2013). Naringenin can 
increase hepatic fatty acid oxidation through PPARs, prevent SREBPs-mediated lipogenesis in 
both liver and muscle, decrease hepatic cholesterol and cholesterol ester synthesis, reduce both 
VLDL-derived and endogenously synthesized fatty acids. Cho, Kim, Andrade, Burgess, and Kim 
(2011) reported that experimental diet treatments (high-fat diet with naringenin - 0.003, 0.006, 
and 0.012%) to normal rats led to maintenance of normal cholesterol levels. An experimental 
diet containing naringenin reduced the plasma, liver, and adipose tissue lipid profile, and 
modulated the fatty acid oxidation-related gene expression as compared to the control group 
(received only high fat diet) (Cho et al., 2011). Naringenin may reduce the hyperlipidemia and 
obesity via activating the PPAR-α transcription factor and upregulating fatty acid oxidation-
related genes such as CPT-1 and UCP2. Zar Kalai et al. (2013) demonstrated that naringenin 
(10 mg/kg) exerted anti-obesity effects against high fat diet-induced obese mice as evaluated by 
enhancing the serum and hepatic lipid metabolism, lipolysis, and lipogenesis-related gene 
expression, when compared to high-fat diet-fed group (Zar Kalai et al., 2013). Furthermore, in 
3T3-L1 cell line, naringenin (6–50 g/mL) inhibited the adipogenesis on murine as evaluated by 
reduced lipid accumulation and upregulated adipocyte protein expression (aP2, ADPN, PPAR, 
STAT5A) when compared to a control group (Richard, Amini-Vaughan, Ribnicky, & Stephens, 
2013). 
 
5. Antidiabetic effect of naringenin 
 
Diabetes is a noncommunicable metabolic disorder which is characterized by sustained 
hyperglycemia associated with either insulin resistance or absence of insulin production (Gowd, 
Jia, & Chen, 2017). Naringenin can improve hyperglycemia by reducing insulin resistance and 
exerting antioxidant activity (Table 2). Acalypha wilkesiana (naringenin-11.12%) is a Southern 
Nigerian plant and has been widely used to treat diabetes mellitus. The aqueous extract of 
Acalypha wilkesiana leaves (doses-100, 200 and 300 mg/kg) treatments for 10 days to alloxan-
induced diabetic rats exhibited antidiabetic activity. The treatment significantly (P < 0.05) 
modulated the plasma markers (glycemia, lipid profile, hepato-specific profile, electrolyte 
profile, atherogenic index, and hematology) and ocular oxidative stress markers as compared to 
diabetic control group (Ikewuchi, Onyeike, Uwakwe, & Ikewuchi, 2011). Cola nitida seed 
extract (3.6% naringenin content) inhibited the carbohydrate-digesting enzyme activities (α-
amylase EC50 = 0.34 mg/mL and α-glucosidase EC50 = 0.32 mg/mL). The extract also inhibited 
the Fe2+-induced lipid peroxidation (MDA) in rat pancreas in a dose-dependent manner, 
indicating its anti-diabetic activity (Oboh, Nwokocha, Akinyemi, & Ademiluyi, 2014). 
 
Hyperglycemia is associated with the production of ROS, which is related to cellular 
genotoxicity in biological systems. In alloxan (75 mg/kg, i. v.)-induced diabetic mice, naringenin 
(50 mg/kg, i. p., 7 days) reduced the peripheral lymphocytes DNA damage as evaluated by comet 
assay. Treatment with naringenin also significantly reduced the body weight, blood 
hematological and immunological parameters as compared to diabetic mice (Orsolic et al., 
2011). Naringenin showed a protective effect against diabetes, possibly by ameliorating 
oxidative stress via improving antioxidant status. Kapoor, Rizvi, and Kakkar (2013) reported that 
pretreatment with naringenin (5 μg) protected against high-glucose (40 mM)-induced primary 
hepatocyte apoptosis as confirmed by improved cell viability (MTT assay), ROS generation, and 
intracellular antioxidant profile (SOD, CAT, GPx). They also found that naringenin improved 
the mitochondrial membrane potential (Cyt-c and AIF/Endo-G translocation), and suppressed the 
caspase-9/3 activation, Bcl-2 family gene expression, intra-nucleosomal DNA damage and 
chromatin condensation (Kapoor et al., 2013). These results suggested that naringenin may 
alleviate the hepatic apoptosis of streptozotocin (STZ)-induced diabetes model. In a Wistar rat 
model, co- and post-treatment with naringenin (50 mg/kg) was also found to alleviate 
intracellular ROS generation, oxidative stress parameters, liver and kidney biomarkers. The 
treatment further ameliorated the mitochondrial membrane dysfunction and expression of genes 
encoding apoptotic proteins (Bax/Bcl-2, Caspase-3/9, AIF/Endo-G) (Kapoor & Kakkar, 2014). 
As a result, naringenin can prevent high glucose-induced apoptosis via scavenging ROS and 
modulate mitochondria-mediated apoptotic pathway. 
 
Furthermore, naringenin (5 and 10 mg/kg) protected from STZ-induced renal impairment. 
Treatment with naringenin for 10 weeks also significantly suppressed the biochemical and 
oxidative stress parameters, renal degradation, TGF-β1/IL-1 upregulation, and kidney apoptosis 
(TUNEL assay) (Roy, Ahmed, Banerjee, & Saha, 2016). Here, naringenin lowered the 
hyperglycemia-mediated oxidative damage, cytokines expression, apoptotic events, and thereby 
alleviated the structural alterations of kidney such as glomerulosclerosis, glomerular basement 
membrane thickening, proximal and convoluted tubules changes, etc. Sirovina, Orsolic, 
Gregorovic, and Koncic (2016) proved the hepato- and reno-protective effect of naringenin. 
Naringenin (50 mg/kg) ameliorated the pathological changes of the liver such as unequal 
vacuolated, higher vacuolated around central veins than Kiernan's spaces, lymphocyte 
infiltrations. The treatment also alleviated the kidney architectural changes, e.g. renal corpuscles 
and tubules changes, narrow bowman's spaces, parietal layer's thickness, and tubule epithelium 
damage, etc. of diabetic mice compared to normal mice (Sirovina, Oršolić, Gregorović, & 
Končić, 2016). 
STZ and nicotinamide (NA)-induced diabetic model exerts the East-Asian non-obese type II 
diabetes (T2D) patients-like-phenotype (Nakamura et al., 2006). In single-dose STZ (50 mg/kg) 
and NA (110 mg/kg)-induced diabetic rats, naringenin (50 mg/kg) treatment ameliorated 
hyperglycemia and oxidative stress (Annadurai et al., 2012). Naringenin can reduce the diabetes 
via possibly protecting pancreatic islets (preserve the remaining β-cell mass and reduce the 
pancreatic islets vacuolization) from ROS-mediated oxidative stress. This compound also 
stimulated the pancreatic β-cells to produce and secrete extra insulin to maintain glucose 
homeostasis. Rahigude, Bhutada, Kaulaskar, Aswar, and Otari (2012) reported the 
neuroprotective effect of naringenin against high-fat diet (HFD)/high-fat emulsion (HFE) with 
STZ (single dose, 35 mg/kg)-induced T2D rats. Naringenin (25, 50 mg/kg) treatments modulated 
the body weight, blood glucose, cognitive behavior dysfunction (reduce locomotor activity and 
inhibit cholinesterase activity), and biochemical changes (decrease MDA, NO, and GSH levels) 
of diabetic rats (Rahigude et al., 2012). Naringenin can modulate the intracellular high-glucose-
induced glucotoxicity in neuron via showing antioxidant activity, which can inhibit the 
cholinesterase activity-induced memory dysfunction in diabetic condition. In addition, Al-Rejaie 
et al. (2015) reported that naringenin (25 and 50 mg/kg, 2 weeks) ameliorated STZ (60 mg/kg)-
induced diabetic neuropathy by lessening the serum glucose, pro-inflammatory cytokines (TNF-
α, IL-1β, IL-6), nitric oxide (NO) production, and oxidative stress markers (MDA). Naringenin 
also improved the insulin levels, antioxidant enzyme activity (GSH, SOD, CAT, GPx, and GR), 
insulin growth factor (IGF) and nerve growth factor (NGF) expression of sciatic nerve, and 
sciatic nerve histology (Al-Rejaie et al., 2015). This study suggested that naringenin showed the 
neuroprotective effect through increasing the activity of antioxidant enzymes of sciatic nerves. 
The reason is that the sciatic nerve cells might be more susceptible to damage by high-glucose-
induced oxidative stress. Retinal damage is one of the most common microvascular 
complications of diabetes induced by oxidative stress. Naringenin (50 mg/kg) protected from 
STZ-induced retina damage by lowering hyperglycemia, oxidative stress markers, and apoptosis 
markers (Bax/Bcl2, caspase-3). This compound also lowered the neuroprotective factors such 
as brain-derived neurotrophic factor, tropomyosin-related kinase B and synaptophysin as 
compared to a diabetic group (Al-Dosari et al., 2017). Naringenin may limit neurodegeneration 
by providing neurotrophic support to protect from retinal damage in diabetic retinopathy 
condition by reducing oxidative stress-induced apoptosis. Vascular endothelial dysfunction is the 
common complication of T2D associated with NO production and free fatty acids (FFA) 
generation. In HFD/STZ-induced diabetic rats and palmitic acid (PA)-induced human umbilical 
vein endothelial cells (HUVECs), naringenin treatments (50 or 100 mg/kg for 6 weeks and 
30 μM) minimized the vascular dysfunction. Naringenin significantly alleviated the blood 
glucose and insulin levels, oxidative stress/antioxidant markers, intercellular adhesion molecule-
1 (ICAM-1), thoracic aorta's pathology, insulin resistance (IR), and inhibited the in-vitro NF-κB 
and ICAM-1 mRNA expression (Ren et al., 2016). As a result, naringenin can modulate vascular 
endothelial dysfunctions in diabetes condition at least in part by suppressing oxidative stress and 
inflammation. Naringenin itself acts as an enhancer for insulin-secreting pancreatic endoderm 
(derived from human embryonic stem cells, hESCs) to reduce gestational diabetes. Naringenin 
treatments to pancreatic endoderm transplanted gestational diabetic mice increased the body 
weight, modulated the high blood glucose and low insulin levels, and improved the antioxidant 
status and reproductive outcome compared to the control group (Xing, Yang, & Wu, 2016). 
 
6. Anti-inflammatory activity of naringenin 
 
Inflammation is a complex biological response directly connected with oxidative stress, obesity, 
and diabetes; which can be ameliorated by naringenin (Table 2). In acetic acid- (4%)-induced 
ulcerative colitis (a subtype of inflammatory bowel disease, IBD), different doses of naringenin 
(25, 50, and 100 mg/kg) significantly lowered the colon weight/length, colon histological 
changes such as colitis with superficial erosions, stromal edema, inflammatory cells infiltration, 
and ulcerative mucosa. Naringenin also reduced the oxidative stress marker (MDA) and 
inflammatory protein (TNF-α, IL-1β, IL-6, PGE2, and NO); increased the mucosal content, 
antioxidant profile (T-GSH, NPSH, SOD, and CAT), total protein level, nucleic acid 
concentration (DNA and RNA) as compared to an acetic acid treated group (Al-Rejaie et al., 
2013). There are several mechanisms which might explain anti-inflammatory activities of 
naringenin including NF-kB and activator protein-1 signals inhibition and increased 
phosphorylation of ERK 5 and P38 MAPK. Naringenin cured the altered kidney and platelet 
injury of high cholesterol-fed rats showing an anti-inflammatory and anti-aggregate activity. Co-
treatments with cholesterol (10 gm/kg) and naringenin (50 mg/kg) for 3 months resolved the 
hematological parameters, lipid profile, renal oxidative stress-related markers, and renal 
histology. The co-treatment also resolved the mRNA expression of kidney and platelets 
membrane such as Ecto-nucleotide triphosphate diphosphohydrolases (NTPDases), ecto-5′-
nucleotidase (CD73), iNOS, TNF-α, IL-6, and NF-kB as compared to high-cholesterol-induced 
group (Chtourou et al., 2016). Lipopolysaccharide (LPS), an endotoxin from the outer 
membrane of the Gram-negative bacterial cell wall has been widely used for inducing 
inflammation. Naringenin (50 and 100 mg/kg) exhibited anti-inflammatory activity against LPS-
induced lung injury by decreasing wet/dry lung weight ratio and tissue biochemical profile 
(MDA, NO, IL-6, and MPO). Naringenin also lowered the lung histological damage (tissue 
damage, alveolar wall thickening, interstitial edema, and inflammatory cell infiltration) and lung 
immunohistochemical expression (NF-κB, iNOS, TNF-α, and caspase-3) (Fouad, Albuali, & 
Jresat, 2016). Naringenin exerted protective effect against acute lung injury via upregulating heat 
shock protein-70 (HSP70), which significantly reduced the inflammatory biomarkers (blocked 
the NF-κB pathway) and impaired the apoptotic pathway (caspases). Another study reported that 
naringenin lessened superoxide anion (KO2)-induced inflammatory pain in mice model via 
modulating pain-like-behavior, mechanical hyperalgesia, and thermal hyperalgesia. The 
treatment also reduced the MPO activity, oxidative stress-related markers, and cytokine 
production (IL-33, IL-10, and TNF-α). In addition, naringenin activated the NO-cGMP-PKG-
KATP channel and related Nrf2/HO-1 signaling pathway (Manchope et al., 2016). Naringenin also 
reduced the LPS-induced inflammatory pain and leukocyte recruitment (Pinho-Ribeiro et al., 
2016a). This study further showed that naringenin (50 mg/kg) treatment lowered the acute pain-
behaviors and mechanical stimuli (such as carrageenan, capsaicin, and PGE2)-induced 
inflammation (Pinho-Ribeiro et al., 2016b). In UVB irradiation-induced skin damage, naringenin 
containing tropical formulation treatment significantly lessened the skin edema, superoxide 
anion and lipid hydroperoxides production, and inflammatory cytokines (TNF-α, IL-1β, IL-6, 
and IL-10). This formulation improved the mRNA expression of antioxidant markers such as 
GPx-1, GR, Nrf2, and HO-1 as compared to an UVB-untreated group (Martinez et al., 2016). 
Naringenin treatments (25, 50 and 100 mg/kg) healed the thermal burn (10 sec immersion in 
90 °C water)-induced skin inflammation. Different doses of compound reversed the pro-
inflammatory cytokines (TNF- α, IL-1β, and IL-6), inflammatory markers (NO, PGE2, caspase-
3, LT-B4, and NF-kB), oxidative stress parameters, and dermal histological changes (Al-
Roujayee, 2017). Naringenin may contribute to promote tissue regeneration via exhibiting 
antioxidant activity (Nrf2/HO-1 pathway) and inhibiting inflammation (NF-kB pathway). In 
pemphigus vulgaris-treated human keratinocyte cell line (HaCaT), naringenin (50, 100 or 
200 μM) reduced the cellular damage via modulating cellular apoptosis, antioxidant activity, and 
cell-cell contacts disruption (cell fragments). Naringenin further modulated the ROS generation 
and mitochondrial transmembrane potential, expression of keratinocyte adhesion molecules 
(Dsg1, Dsg3, and E-cadherin) and NOD2-mediated NF-kB pathway (NOD2, RIPK2, and NF-kB 
p-p65) (Liang et al., 2017). 
 
7. Hepato- and reno-protective effect of naringenin 
 
Naringenin showed hepato- and reno-protective effect via exhibiting antioxidant and free radical 
scavenging activity against oxidative stress induced by different toxicants such as chemicals, 
drugs, heavy metals, etc. (Table 3). Oxytetracycline is an antibiotic that produces severe hepatic 
steatosis as an adverse effect. Oxytetracycline administration (i.p., 200 mg/kg for 15 days) 
significantly increased the hepato-specific biochemical profile such as aspartate transaminase 
(AST), alanine transaminase (ALT), alkaline phosphatase (ALP), lactate dehydrogenase (LDH), 
and bilirubin. Oxytetracycline drug also improved the oxidative stress profile such as 
thiobarbituric acid reactive substances (TBARS) and lipid hydroperoxides, reduced the 
antioxidant profile (Vit-C and -E, GSH, SOD, CAT, and GPx), and altered the hepatic histology. 
However, oxytetracycline-induced hepatotoxicity was ameliorated by naringenin (50 mg/kg) 
treatment by reducing lipid peroxidation and enhancing cellular antioxidant defense system (Pari 
& Gnanasoundari, 2006). Jayaraman, Veerappan, and Namasivayam (2009) also reported the 
hepatoprotective effect of naringenin against ethanol (20%, 6 g/kg)-induced hepatotoxicity 
(Jayaraman et al., 2009). Carbon tetrachloride (CCl4) is widely used to induce hepatic damage of 
animal model to evaluate the in vivo hepatoprotective effect of new compound or agent. In CCl4-
induced acute hepatic failure, naringenin (100 mg/kg) lessened the hepatic biochemical 
parameters, oxidative stress markers, apoptosis markers (caspase-3, -8, and -9) (Yen, Wu, Lin, 
Cham, & Lin, 2009). Naringenin treatments further lowered the pro-inflammatory protein 
(iNOS, COX-2, and TNF-α) via upregulating the anti-oxidative defense protein (HO-1 and Nrf-
2) (Esmaeili & Alilou, 2014). Accumulation of heavy metals (such as cadmium (Cd), arsenic 
(As), lead (Pb), etc.) can damage body organs via cellular oxidative damage by ROS. Naringenin 
(50 mg/kg) protected against cadmium (Cd)-/arsenic (As)-/lead (Pb)- induced hepatotoxicity via 
exerting antioxidant scavenging activity (Jain, Yadav, Bozhkov, Padalko, & Flora, 2011; 
Ozkaya, Sahin, Dag, & Ozkaraca, 2016; Renugadevi & Prabu, 2010). In old-aged rats, 
naringenin treatment improved the hepatic health, antioxidant status, and membrane 
phospholipid compositions (n-3 PUFA and n-6/n-3 PUFA ratio) in the liver tissue (Miler et al., 
2016). As a result, depletion of n-3 PUFA content and enhancement of n-6/n-3 PUFA ratio is 
associated with age-related liver diseases, which can be revised by naringenin. 
Hypercholesterolemia produces free fatty acids and induces lipotoxicity such as hepatic fibrosis 
or inflammation. Naringenin (50 mg/kg) significantly lowered cholesterol-induced hepatic 
inflammation via decreasing plasma lipid profile, oxidative stress profile, inflammatory markers 
(iNOS, Emr1, TNF-α, IL-1 β, IL-6, and NF-κB). This compound further lessened the ECM 
dysregulation such as matrix metalloproteinases (MMP) −2/-9 expression and pro MMP-9/-2 
activities, DNA fragmentation, and histological damages (Chtourou, Fetoui, Jemai, et al., 2015). 
Here, naringenin markedly lowered the lipid and protein oxidations, improved antioxidant status, 
and suppressed ECM degradation by modulating the levels of necrotic inflammation. Simvastatin 
(SV) is used as a hypocholesterolemic drug that can cause hepatic damage. Co-treatment with 
SV (20 and 40 mg/kg/day) and naringenin (50 mg/kg/day) exerted hepatoprotective effect via 
significantly modifying liver functions, oxidative stress markers (MDA, GSH, SOD, GST, 
CAT), DNA fragmentation, and histopathological changes compared to vehicle control and SV 
control (Motawi, Teleb, El-Boghdady, & Ibrahim, 2014). Thus, concurrent treatment with SV 
and naringenin can manage the SV-induced hepatotoxicity, which could be an effective 
treatment for hypercholesterolemia patients. Isoniazid and rifampicin are the anti-tuberculosis 
drugs, and both can exert the hepatotoxic effect via generating ROS causing the mitochondrial 
permeability and hepatocyte death. Naringenin (50 and 100 mg/kg) protected from drugs 
(isoniazid and rifampicin)-induced oxidative stress and hepatic histological damage via 
possessing antioxidant and anti-apoptotic activities (inhibited the TUNEL positive cell, caspase-
3, Bax/Bcl2 pathway) (Wang, Fan, Zhang, Nie, & Li, 2016). 
 
Ethanolic extract of Algerian propolis- 100 mg/kg (contained 14.27% naringenin) significantly 
minimized the doxorubicin drug (10 mg/kg)-induced kidney toxicity. This extract significantly 
restored the kidney profile (serum creatinine, γ-glutamyltranspeptidase enzyme activity) as well 
as oxidative stress-related markers (MDA and GSH) (Boutabet, Kebsa, Alyane, & Lahouel, 
2011). This extract reduced the kidney toxicity either by increasing the rate of GSH or by 
scavenging free radicals. Hermenean et al. (2013) explained that naringenin protected (50 mg/kg) 
against CCl4-induced renal dysfunction. Naringenin treatments for seven days significantly 
suppressed the renal oxidative stress-related markers (DA, SOD, CAT, GPx, and GSH). 
Naringenin treatment significantly reformed the pathohistological changes of kidney tissue such 
as tubular renal epithelial vacuolization, glomerular atrophy, medulla area necrosis, collagen 
fibers around renal corpuscles and tubules, lipids proliferation in renal parenchyma, TGF-β1 
distribution in glomeruli and tubular areas, and T-cell immunoglobulin (TIM-1) distribution in 
cortical area (Hermenean et al., 2013). Nephroprotective effect of naringenin was also proved 
by Fouad, Albuali, Zahran, and Gomaa (2014). They suggested that naringenin protects against 
the gentamycin-induced kidney toxicity as well as exhibiting antioxidant and anti-inflammatory 
activities. The results revealed that naringenin treatments alleviated the renal parameter 
(creatinine), oxidative stress-related markers (MDA and GPx), inflammatory markers (NO and 
IL-8). They also observed that naringenin improved the renal architectural damages such as 
tubular necrosis, tubular dilatation, vacuolization, epithelial lining desquamation, cast formation 
in tubular lumen; and decreased the immunoreactivity (KIM-1, iNOS, VEGF, and caspase-9) of 
the renal tubular cells (Fouad et al., 2014). In daunorubicin drug-induced genotoxicity, 
naringenin ameliorated the kidney biochemical profile, renal histology, protein expression of 
AT1R and ERK1/2-NFκB p65 signaling pathway (p67phox, ET1, ETAR, p-ERK1/2, p-NFκB 
p65, IFNγ, IL-6, TNFR1, and COX2). Naringenin also ameliorated the ER stress and apoptosis 
(GRP78, CHOP, cleaved caspase-7, and caspase-12 levels), and inflammatory marker (PPARγ) 
(Karuppagounder et al., 2015). Based on their research, naringenin can improve the renal 
function of nephrotoxic rats via attenuating AT1R, ERK1/2-NFκB p65 signaling pathway. 
 
Table 3. Organo-protective effects of Naringenin. 
Hepato- and reno-protective effect 
Source Compound/Extract and dose Model (in vitro/in vivo) Research Outcome Significance 
Sigma-Aldrich Naringenin (50 mg/kg) Oxytetracycline-induce rats • Ameliorated the hepato-specific biochemical profile (AST, ALT, 
ALP, LDH), bilirubin), oxidative stress profile (TBARS, lipid 
hydroperoxides), antioxidant profile (Vit-C and -E, GSH, SOD, 
CAT, GPx), and histological damage. 
Hepatoprotective effect 
(Pari & Gnanasoundari, 
2006). 
Sigma-Aldrich Naringenin (50 mg/kg) Ethanol-induced hepatotoxicity • Significantly improved the biochemical parameters, oxidative 
stress/antioxidant markers, and histopathological changes. 
Hepatoprotective effect 
(Jayaraman et al., 2009). 
Sigma-Aldrich Naringenin (100 mg/kg) Carbon tetrachloride-induced 
rats 
• Reduced the hepatic biochemical parameters, oxidative stress 
markers, apoptosis markers (caspase-3, -8, and -9). 
Hepatoprotective effect 
(Yen et al., 2009). 
Sigma-Aldrich Naringenin (50 mg/kg) Carbon tetrachloride-induced 
rats 
• Reduced the hepatic biochemical parameters, oxidative stress 
markers, pro-inflammatory protein (iNOS, COX-2, and TNF-α). 
• Upregulated the anti-oxidative defense protein (HO-1 and Nrf-2). 
Anti-inflammatory and 
anti-hepatotoxic effect 
(Esmaeili & Alilou, 
2014). 
Sigma-Aldrich Naringenin (50 mg/kg) Cadmium (Cd)-induced rats • Ameliorated the biochemical profile (AST, ALT, ALP, LDH, GGT, 
and TB), oxidative stress profile (TBARS, lipid hydroperoxides), 
antioxidant profile (Vit-C and -E, GSH, SOD, CAT, GPx), and 
histological damage. 
Hepatoprotective effect 
(Renugadevi & Prabu, 
2010). 
Sigma-Aldrich Naringenin (50 mg/kg) Arsenic (As)-induced rats • Increased the antioxidant profile (GSH, SOD, and CAT) and 
decreased the oxidative stress profile (GST and TBARS). 
Hepatoprotective effect 
(Jain et al., 2011) 
Merck KGaA Naringenin (50 mg/kg) Lead (Pb)-induced rats • Increased the antioxidant profile and decreased the oxidative stress 
profile. 
Hepatoprotective effect 
(Ozkaya et al., 2016) 
Sigma-Aldrich Naringenin (15 mg/kg) Old-aged Wistar rats • Improved the hepatic antioxidant status (SOD 1/2, GPx, GR, and 
GSH), membrane phospholipid composition (of n-3 PUFA and n-
6/n-3 PUFA ratio). 
• Significantly decreased the TBARS without affecting serum 
biochemical (AST, ALT), and liver histology. 
Hepatoprotective effect 
(Miler et al., 2016). 
Sigma-Aldrich Naringenin (50 mg/kg) Cholesterol-induced rats • Lowered the plasma lipid profile, oxidative stress profile, 
inflammatory markers (iNOS, Emr1, TNF-α, IL-1 β, IL-6, and NF-
κB), ECM dysregulation (matrix metalloproteinases (MMP) −2/-9 
expression and proMMP-9/-2 activities), DNA fragmentation, and 
histological damage. 
Hypolipidemic, anti-
inflammatory and anti-
hepatotoxic effect 
(Chtourou, Fetoui, et al., 
2015). 
Alfa Aesar Naringenin (50 mg/kg) Adult female Wistar albino rats • Significantly improved the liver function, oxidative stress markers, 
DNA fragmentation, and histopathological changes. 
Hepatoprotective effect 
(Motawi et al., 2014) 
Sigma-Aldrich Naringenin (50 and 100 mg/kg) Drugs (Isoniazid and 
rifampicin)-induced mice 
• Improved the serum biochemical (AST, ALT), liver histology, 
oxidative stress/anti-oxidant parameters (MDA, GSH, SOD), and 
hepatocyte apoptosis (TUNEL assay). 
Hepatoprotective effect 
(Wang et al., 2016). 
Algerian 
propolis 
Ethanolic extract- 100 mg/kg 
(naringenin-14.27%) 
Doxorubicin-induced rats • Significantly restored the kidney profile (serum creatinine, gamma-
glutamyltranspeptidase enzyme activity) and oxidative stress-related 
markers (MDA, GSH). 
Reno-protective effects 
(Boutabet et al., 2011). 
Sigma-Aldrich Naringenin (50 mg/kg) Carbon tetrachloride-induced 
mice 
• Reduced the renal oxidative stress-related markers (DA, SOD, CAT, 
GPx, GSH) and pathohistological changes of kidney tissue. 
Reno-protective effects 
(Hermenean et al., 
2013). 
Sigma-Aldrich Naringenin (50 mg/kg) Gentamicin-induced rats • Ameliorated the renal parameter (Creatinine), oxidative stress-
related markers (MDA, GPx), inflammatory markers (NO and IL-8). 
• Improved the renal histology, and the immunoreactivity (decreased 
the KIM-1, iNOS, VEGF, caspase-9, and increased the surviving 
expression) of the renal tubular cells. 
Antioxidant, anti-
inflammatory, and 
renoprotective effects 
(Fouad et al., 2014). 
Sigma-Aldrich Naringenin (20 mg/kg) Daunorubicin-induced rats • Ameliorated the renal biochemical profile, histology, protein 
expression of AT1R and ERK1/2-NFκB p65 signaling pathway, ER 
stress and apoptosis, and inflammatory markers. 
Anti-inflammatory, anti-
apoptosis, and reno-
protective effects 
(Karuppagounder et al., 
2015). 
Anti-hypertensive and cardioprotective effect 
Dracocephalum 
rupestre 
Naringenin-7-O-glucoside (5–
20 μM) 
Doxorubicin-induced 
cardiomyocytes (H9c2) cell 
line 
• Improved the cell viability, cellular morphological injury, 
intracellular ROS generation, extracellular LDH content, CK level, 
cellular GSH-Px activity, and intracellular Ca2+ concentration. 
Antioxidant, cardo-
protective and anti-
apoptosis effects (Han et 
al., 2012). 
Sigma-Aldrich Naringenin (50 μM) H2O2-treated H9c2 cell line • Improved the cell viability, oxidative stress-related parameters 
(glutathione, MDA, NO, catalase, GSH-Px, and GST), transcription 
gene (Akt, NF-κB, and Caspase 3), and Nrf2/ARE signaling. 
Antioxidant, cardo-
protective and anti-
inflammatory effects 
(Ramprasath et al., 
2014). 
Sigma-Aldrich Naringenin (25 and 50 mg/kg) Cardiorenal syndrome rats • Improved the lipid profile, cardiac inflammatory markers, oxidative 
stress parameters, and Nrf2/GCLc-regulated GSH synthesis. 
Antioxidant, cardo-
protective and 
renoprotective effects 
(Liu et al., 2016). 
Sigma-Aldrich Naringenin (50 mg/kg) Doxorubicin-induced rat • Improved the body weight, heart weight, cardiac enzymes markers 
(LDH activity and troponin T (cTnT)), oxidative stress-related 
parameters (MDA, SOD, CAT, GPx), mRNA expression of 
inflammatory markers (TGF-β1, TNF-α, IL-6, and IL-10), and heart 
architecture. 
Antioxidant, cardo-
protective and anti-
inflammatory effects 
(Subburaman et al., 
2014). 
Sigma-Aldrich Naringenin (50 mg/kg) Cholesterol-induced rat • Reduced the relative heart weights (%), cardiac lipid profile, serum 
cardiac markers, antioxidant status, heart mitochondrial enzymes 
marker, cardiac cell death marker expression. 
• Improved the cardiac tissue histology. 
Antioxidant, cardio-
protective effects 
(Chtourou, Slima, 
Makni, Gdoura, & 
Fetoui, 2015). 
Sigma-Aldrich Naringenin (40 μM) H2O2-induced H9c2 cell line • Modulated the ROS levels, DNA damage, the mitochondrial 
potassium channels, mitochondrial oxidative metabolism activity, 
estradiol level, and estrogen-related pathways (ER and VDR). 
Anti-aging and cardio-
protective effects (Da 
Pozzo et al., 2017). 
Sigma-Aldrich Naringenin (50 mg/kg) Monocrotaline-induced 
pulmonary hypertensive rats. 
• Improved the body, heart and lung weights, heart rate, blood 
pressure, electrocardiography, echocardiography. 
• Ameliorated the oxidative stress-related markers, inflammatory 
markers, nitric oxide synthase, total nitrate/nitrite (NOx) level, 
apoptosis markers, tissues histological changes. 
Anti-oxidant, anti-
inflammation, 
hypotensive, and anti-
apoptosis effect (Ahmed 
et al., 2014). 
Schinus 
terebinthifolius 
Methanolic extract (30 mg/kg) 
(contain naringenin) 
Wistar rats and albino male 
mice 
• Reduced blood pressure (Systolic, median, and diastolic), and relax 
the vasoconstriction 
Anti-oxidant and 
antihypertensive effect 
(de Lima Gloria et al., 
2017). 
Neuroprotective effect 
Sisco research 
Lab, India 
Naringenin (25 and 50 mg/kg) Chronic construction injury-
induced rats 
• Attenuated the pain induced physical and behavioral changes 
(thermal hyperalgesia, cold allodynia, mechanical hyperalgesia, and 
foot deformity), oxidative stress markers (MDA, GSH, NO). 
Antioxidant and anti-
neuropathic pain effects 
(Kaulaskar et al., 2012). 
Sigma-Aldrich Naringenin (50 mg/kg) Intracerebroventricular- 
streptozotocin-induced rats 
• Improved the behavior change, spatial learning and memory, choline 
acetyltransferase (ChAT) expression, and hippocampus histology. 
• Decrease the non-enzymatic parameters (4-HNE, MDA, TBARS, 
H2O2, PC, and GSH), increase the enzymatic activity (GPx, GR, 
GST, SOD, CAT, and Na+/K + - ATPase). 
Neuroprotective effect 
(Khan et al., 2012). 
Sigma-Aldrich Naringenin (100 mg/kg) Beta-amyloid (Aβ)-induced 
rats 
• Improved the behavioral change, hippocampus oxidative stress 
markers (MDA, nitrate level, and SOD) and apoptosis (DNA 
fragmentation). 
Neuroprotective effect 
(Ghofrani et al., 2015). 
Sigma-Aldrich Naringenin (10 mg/kg) Hypoxia-induced swiss albino 
mice 
• Ameliorated the behavioral changes (poking and rearing behavior), 
neurological damage by altering the hypoxic brain, protein, and 
immunoexpression of the cortex, stratum radiatum and hippocampus 
(VEGF, HIF1α, Hsp70, Hsp90, CHIP panel, caspase-3, and 
ubiquitination). 
Neuroprotective effect 
(Sarkar et al., 2012). 
Sigma-Aldrich Naringenin (100 μM) Carbaryl-induced mouse 
neuroblastoma cell line 
(Neuro 2A) 
• Improved the cell viability, ROS generation, mitochondrial 
membrane potential, apoptotic genes expression (Bax/Bcl2, caspase-
3). 
Neuroprotective effect 
(Muthaiah et al., 2013). 
Sigma-Aldrich Naringenin (50 mg/kg) MCAO-induce focal cerebral 
ischemia rats 
• Improved the behavioral changes (neurological deficits, motor 
function, grip performance, and somatosensory deficit), upregulate 
the antioxidant profile, decreases the infarct size, lowered 
inflammatory parameters (MPO, NO, and cytokines), and improved 
Anti-oxidant, anti-
inflammatory and 
neuroprotective effect 
((Raza et al., 2013). 
brain tissue protein and immunoexpression (SOD, NF-kB, iNOS, 
COX-2, and Iba-1). 
Sigma-Aldrich Naringenin (50 mg/kg) Iron-induced cerebral cortex 
neurotoxic rats 
• Suppressed the oxidative stress-related markers, antioxidant enzyme 
activities, Na+/K + - ATPase and ChAT activity, DNA 
fragmentation, and cerebral cortex histology. 
Anti-oxidant and neuro- 
protective effect 
(Chtourou et al., 2014). 
Sigma-Aldrich Naringenin (50 mg/kg) Iron-induced hippocampus 
neurotoxic rats 
• Suppressed the behavioral changes (anxiety-like behavior, locomotor 
activity and exploratory behavior, anxiolytic-like behavior), 
oxidative stress-related markers, antioxidant enzyme activities, 
ectonucleotidase and ChAT activity. 
Anti-oxidant and neuro-
protective effect 
(Chtourou, Slima, 
Gdoura, & Fetoui, 2015) 
Sigma-Aldrich Naringenin (0.30 mM) Tungsten (W)-induced rats • Improved the oxidative stress-related parameters (ROS level, MDA, 
GSH, GSSG, GPx), biogenic amines (dopamine, norepinephrine, 
and 5-hydroxytryptamine), brain AChE and MAO activity. 
Anti-oxidant and 
neuroprotective effect 
(Sachdeva et al., 2015).  
Naringenin (70 mg/kg for in 
vivo) and (40 and 80 μM 
for in vitro) 
6-hydroxydopamine (6-
OHDA)-induced human 
neuroblastoma cells line (SH-
SY5Y) and mice model 
• Improved the cell viability, LDH release, ROS production and GSH 
level, Nrf2/ARE and JNK/p38 pathway, immunoreactivity and 
protein expression of tyrosine hydroxylase (striatum and SNc 
section of the brain). 
Anti-oxidant, anti-
apoptosis, and neuro-
protective effect (Lou et 
al., 2014).  
Naringenin Oxygen and glucose 
deprivation-cortical neuron 
cells and neonatal Sprague-
Dawley rats 
• Improved the neuron cell proliferation, oxidative stress-related 
profile (ROS, MDA, and SOD), mitochondrial dysfunction, cerebral 
edema and neurological defects, Nrf2 protein regulation and 
translation, apoptosis markers (caspase −3/-9, Bax/Bcl2, and DNA 
fragmentation). 
Anti-oxidant, anti-
apoptosis, and 
neuroprotective effect 
(Wang et al., 2017). 
 
Naringenin (50 mg/kg) d-galactose-induced mice • Improved the body weight and organ index, lessen the behavioral 
changes (locomotion, spatial learning, and memory performance), 
restored the brain histopathological, reduced the neuronal loss and 
apoptosis (TUNEL and Nissl staining of hippocampus and cortex), 
oxidative stress-related markers, and PI3K/Akt/Nrf2 pathway. 
Anti-oxidant, anti-
apoptosis, and neuro-
protective effect (Zhang 
et al., 2017; Zhang, Liu, 
et al., 2017). 
 
8. Antihypertensive and cardioprotective effect of naringenin 
 
Naringenin exhibits well-verified antihypertensive and cardioprotective effects (Table 3). In 
doxorubicin drug-induced cardiomyocytes (H9c2), naringenin-7-O-glucoside improved the cell 
viability and cellular glutathione peroxidase (GSH-Px) activity. Naringenin-7-O-glucoside 
further lessened the cellular morphological injury, intracellular ROS generation and Ca2+ 
concentration, extracellular lactate dehydrogenase (LDH) content, and creatinine kinase (CK) 
levels (Han et al., 2012). According to their results, naringenin protected from cardiotoxicity by 
inhibiting cell death, increasing antioxidant activity, decreasing cellular calcium-overload, and 
increasing mitochondrial function. Subburaman, Ganesan, and Ramachandran (2014) also 
explained the protective effect against doxorubicin-induced cardiotoxicity in the rat model. They 
found out that naringenin (50 mg/kg) treatments significantly modulated the body weight, heart 
weight, cardiac enzymes markers (LDH activity and Troponin T (cTnT)), oxidative stress-related 
parameters (MDA, SOD, CAT, and GPx). Naringenin treatment further revised the mRNA 
expression of inflammatory markers (TGF-β1, TNF-α, IL-6, and IL-10), and cardiac tissue 
architectural damage such as muscle fibers separation, inflammatory infiltration, myocardial 
tissue degeneration, and myofibrillar loss, etc. as compared to a doxorubicin-treated group 
(Subburaman et al., 2014). Also, naringenin reduced the H2O2-treated H9c2 damage by reversing 
cell viability, oxidative stress-related parameters (glutathione, MDA, NO, catalase, GSH-Px, and 
GST). Naringenin modulated the gene transcription (Akt, NF-κB, and caspase 3), and Nrf2/ARE 
signaling-mediated cellular defense system compared to a H2O2-treated group (Ramprasath et al., 
2014). Authors found that naringenin showed a cardioprotective effect against oxidative stress-
induced inflammatory stimuli by upregulating Nrf2/ARE and Akt signaling pathway, and 
downregulating NF-kB and caspase 3-dependent apoptosis pathway. Da Pozzo et al. (2017) also 
proved that naringenin affected H2O2-induced H9c2 cells senescence via modulating the ROS 
levels, DNA damage. Naringenin also modulated the mitochondrial potassium channels, 
mitochondrial oxidative metabolism activity, estradiol level and estrogen-related pathways (ER 
and VDR) (Da Pozzo et al., 2017). Besides in cardiac fibroblasts, naringenin improved the 
cardiac function via upregulating the Nrf2 and/or γ-glutamylcysteine ligase (GCLc) expression-
mediated antioxidant effect (Liu, An, & Gao, 2016). Furthermore, naringenin inhibited the 
cholesterol-induced cardiotoxicity in rats, by altering the relative heart weights (%), cardiac lipid 
profile (TC, TG, FFA, and phospholipids), serum cardiac markers (CK and LDH), and 
antioxidant status (CAT, GPx, SOD, GSH, NPSH, Vit C, and Vit E). Naringenin treatment 
improved the heart mitochondrial enzymes markers (NADH dehydrogenase, succinate-
cytochrome c oxidoreductase, cytochrome c reductase, and ATP synthase), reduced the cardiac 
cell death markers (TNF-α, Receptor interacting protein 3 (RIP3), and DNA fragmentation), and 
cardiac tissue histological damage such as disorganized myocardial fibers as compared to a 
disease control group (Chtourou, Slima, Makni, et al., 2015). Naringenin reduced the cholesterol-
induced cardiotoxicity, at least in part, by ameliorating RIP3-TNF-α mediated necroptosis 
pathway. 
 
In monocrotaline (60 mg/kg)-induced pulmonary hypertensive rats, co-treatments with l-arginine 
(500 mg/kg) and naringenin (50 mg/kg) modified the body, heart, and lung weights, heart rate, 
blood pressure, electrocardiography, echocardiography. It also improved the oxidative stress-
related markers (MDA and GSH), inflammatory markers (MPO and TNF-α), nitric oxide 
synthase (iNOS and eNOS), total nitrate/nitrite (NOx) level, apoptosis markers (TGF-β and 
caspase-3), and histological changes of the right ventricle and lung tissues (Ahmed, Obaid, Zaki, 
& Agha, 2014). Therefore, this co-administration provided the additional benefits via improving 
antioxidant activity, preserving NO beneficial effects, stimulating eNOS expression, and 
inhibiting iNOS overexpression, and its associated inflammatory and apoptosis cascades. 
Methanolic extract of Schinus terebinthifolius (30 mg/kg) (containing naringenin) showed the 
antihypertensive effect as evaluated by improved in vitro antioxidant activity, reduced blood 
pressure (systolic, median, and diastolic), and vasorelaxant effect (measured by rotarod test) (de 
Lima Gloria et al., 2017). 
 
9. Neuroprotective effect of naringenin 
 
Metabolic syndromes are the major risk factors for neurodegeneration and congestive 
dysfunction, which can be suppressed by naringenin (Table 3). Naringenin (25 and 50 mg/kg) 
showed protective effect against chronic construction injury (CCI)-induced neuropathic pain in 
the rat model by attenuating the pain-induced physical and behavioural changes (thermal 
hyperalgesia, cold allodynia, mechanical hyperalgesia, and foot deformity) as well as oxidative 
stress markers (MDA, GSH, and NO) (Kaulaskar, Bhutada, Rahigude, Jain, & Harle, 2012). 
Authors suggested that naringenin lowered the neuropathic pain by inhibition of nitric oxide 
pathway and amelioration of oxidative stress. Intracerebroventricular-streptozotocin (ICV-STZ) 
(3 mg/kg; 5 μl per site) injection to rat significantly altered the normal behavior (spatial learning 
and memory dysfunction), altered the non-enzymatic parameters in the hippocampus (4-HNE, 
MDA, TBARS, H2O2, PC, and GSH). ICV-STZ also reduced the enzymatic profiles in the 
hippocampus (GPx, GR, GST, SOD, CAT, and Na+ K+- ATPase), decreased choline 
acetyltransferase (ChAT) expression, and transformed the hippocampus histology such as 
shrunken neuron, dense/hyper chromatic nuclei, and clear space between neuron. All 
abnormalities were reversed by naringenin pre-treatment (50 mg/kg) (Khan et al., 2012). 
Neuroprotective effect of naringenin against beta-amyloid (Aβ)-induced learning, and memory 
dysfunction rats were further evaluated by improved behavioral change, hippocampus oxidative 
stress-related markers (MDA, nitrate level, and SOD) and apoptosis (DNA fragmentation) 
(Ghofrani et al., 2015). Their findings suggest that naringenin pretreatment attenuated the Aβ-
induced Alzheimer's disease via migrating lipid peroxidation and apoptosis, and its beneficial 
effect was possibly mediated through the estrogenic pathway. 
 
In an iron-induced rat model, naringenin lowered the cerebral cortex and hippocampus 
neurotoxicity by modifying behavioral changes such as anxiety-like behavior, locomotor activity, 
and exploratory behavior. Naringenin further improved the oxidative stress-related markers, 
antioxidant enzyme activities, mitochondrial enzyme markers, Na+/K+- ATPase, ChAT, and 
ectonucleotidase activity, DNA fragmentation, and cerebral cortex histology (Chtourou, Fetoui, 
& Gdoura, 2014; Chtourou, Slima, Gdoura, et al., 2015). Naringenin can modulate cholinergic 
neurotransmission resting membrane potential of neurons via improving antioxidant defense 
system and preserving the cellular integrity. These effects can improve the iron overload-induced 
anxiogenic-like behavior, possibly by altering AChE and E-NTPDases activities. Exposure of 
tungsten (W) altered the normal neurological function by producing the neuro-oxidative damage. 
Naringenin (0.30 mM) treatment to tungsten (W) exposure rat, significantly ameliorated the 
oxidative stress-related parameters (ROS, MDA, GSH, GSSG, and GPx), biogenic amines 
(dopamine, norepinephrine, and 5-hydroxytryptamine), brain AChE, and MAO activity 
(Sachdeva, Pant, Kushwaha, Bhargava, & Flora, 2015). According to the authors, naringenin 
exerted a neuroprotective effect by reducing sodium tungstate-induced oxidative stress, which 
leads to neurotransmitter levels alteration in different brain regions. 
 
Hypoxia produced the behavioral changes (poking and rearing behavior) and neurological 
damage by altering the hypoxic brain (neurons degeneration in the cortex, stratum radiatum, and 
hippocampus region). Hypoxia also altered the protein and immunoexpression of cortex, stratum 
radiatum, and hippocampus (VEGF, HIF1α, Hsp70, Hsp90, CHIP panel, caspase-3, and 
ubiquitination) compared to normoxia group, which is improved by naringenin (10 mg/kg) 
treatments (Sarkar, Angeline, Anand, Ambasta, & Kumar, 2012). Naringenin has the potential to 
reverse the hypobaric hypoxia-mediated physiological impairments such as misfolded proteins 
accumulation in the cellular environment, increased oxidative stress, and induction of apoptosis. 
All these biological disturbances effect leads to neuronal cell death and neurodegeneration. 
Wang et al. (2017) unveiled that naringenin could protect against oxygen-glucose-deprivation 
(OGD)-induced ischemic stroke. The results showed that naringenin treatment alleviated the 
neuron cell proliferation, biochemical indices (ROS, MDA, and SOD), mitochondrial 
dysfunction, cerebral oedema, and neurological defects. Naringenin also regulated the 
localization of the Nrf2 protein and reduced the apoptosis markers (caspase −3/-9, Bax/Bcl2, and 
DNA fragmentation) (Wang et al., 2017). Naringenin can modulate the ischemic cerebrovascular 
diseases by lowering apoptosis and oxidative stress through upregulating Nrf2 signaling 
pathway. Combination of naringenin and lipoic acid (VNAL-100 mg/kg) also exerted the 
synergistic effect against OGD-induced hypoxia and reoxygenation of neuronal culture as 
evaluated by LDH, SOD and intracellular antioxidant capacity (Saleh, Saleh, Connell, & Song, 
2017). 
 
In mouse neuroblastoma cell line (Neuro 2A), naringenin (100 μM) reduced the carbaryl-induced 
neurotoxicity via improving cell viability, ROS generation, mitochondrial membrane potential, 
expression of genes involved in apoptosis (Bax/Bcl2 and caspase-3) (Muthaiah, Venkitasamy, 
Michael, Chandrasekar, & Venkatachalam, 2013). Based on their results from MTT and FACS 
analysis, naringenin could improve the cell survival through maintaining the mitochondrial 
membrane potential, upregulating anti-apoptotic gene Bcl-2, and downregulating pro-apoptotic 
genes (Bax and caspase-3). Naringenin (50 mg/kg) attenuated the ischemic stroke in rat model 
via improving behavioral changes such as neurological deficits, motor function, grip 
performance, and somatosensory deficits. The treatment significantly modulated the altered 
antioxidant profile, infarct size, and inflammatory parameters (MPO, NO, and cytokines). Also, 
naringenin modified the protein and immuno expression of brain tissue (SOD, NF-kB, iNOS, 
COX-2, and Iba-1) (Raza et al., 2013). According to their study, pretreatment of naringenin can 
reduce cerebral ischemia/reperfusion injury by attributing anti-oxidant, free radical-scavenging, 
and anti-inflammatory activities. These effects are more likely to be associated with the 
downregulation of NF-kB signaling pathway. In 6-hydroxydopamine (6-OHDA)-induced 
Parkinson's disease (PD) both in human neuroblastoma SH-SY5Y cells line and in mice model, 
naringenin compound improved the cell viability, LDH release, ROS production, GSH level, 
Nrf2/ARE pathway, and apoptotic signaling pathway (JNK/p38). Naringenin also improved the 
immunoreactivity and protein expression of tyrosine hydroxylase (striatum and SNc section of 
the brain) (Lou et al., 2014). Naringenin resolved the 6-OHDA-induced Parkinson's disease via 
activating Nrf2/ARE pathway and inhibiting apoptotic signaling pathway (JNK/p38). Naringenin 
showed an anti-aging effect against d-galactose-induced behavioral dysfunction and neurological 
deficits via modifying body weight and organ index. Naringenin also modified the behavioral 
changes (locomotion, spatial learning, and memory performance), brain histopathological 
changes, neuronal loss and apoptosis (TUNEL and Nissl staining of hippocampus and cortex). 
This compound reduced the oxidative stress-related markers and improved the endogenous 
antioxidant defense system by activating PI-3K/Akt/Nrf2 pathways (Zhang et al., 2017; Zhang, 
Liu, et al., 2017). 
 
 
Fig. 3. Major steps of naringenin production in plants. PAL, Phenyl-alanine ammonia lyase; 
TAL, Tyrosine ammonia lyase; C4H, Cinnamate 4-hydroxylase; 4CL, 4-coumarate: CoA ligase; 
CHS, Chalcone synthase; CHI, Chalcone isomerase. 
 
10. Potential sources of naringenin 
 
Naringenin production has become an attractive target because of its diverse biological functions 
in plants and beneficial effects on human. Normally, naringenin is obtained from citrus fruit 
using the extraction and purification method. Generally, in plants, naringenin and its derived 
flavonoid compounds are synthesized from the phenylpropanoid pathway. Except for some 
flavonoids, all the compounds can be biosynthesized from a common chalcone unit. Malonyl-
CoA and 4-coumaroyl-CoA serve as precursor molecules for naringenin biosynthesis. 4-
coumaroyl-CoA is produced by the enzymatic conversion of l-tyrosine or phenylalanine to 4-
coumaric acid via tyrosine ammonia lyase (TAL)/phenylalanine ammonia lyase (PAL) followed 
by 4-coumarate: CoA ligase (4CL). The other precursor malonyl-CoA is originated from 
carbohydrate metabolism pathway. In details, TAL and PAL convert tyrosine and phenylalanine 
to the phenylpropanoids p-coumaric acid and cinnamic acid, respectively. Another additional 
enzyme named cinnamate 4-hydroxylase (C4H) further converts the cinnamic acid to p-coumaric 
acid. After that, 4CL converts p-coumaric acid into 4-coumaroyl-CoA by using one molecule of 
ATP and one molecule of coenzyme-A (CoA). One molecule of activated 4-coumaroyl-CoA is 
condensed with three malonyl-CoA by chalcone synthase (CHS) and formed the unstable yellow 
naringenin chalcone. The resulting unstable naringenin chalcone is converted into stable cyclic 
naringenin by the chalcone isomerase (CHI) (Fig. 3) (Lewinsohn, Britsch, Mazur, & Gressel, 
1989; Martens & Mithöfer, 2005; Wu et al., 2014). Moreover, the addition of a sugar moiety 
with the naringenin aglycones sequentially converts the naringenin aglycones into the naringenin 
glycosides (Fig. 1) (Lewinsohn et al., 1989). 
 
Distribution of naringenin in different parts of fruit depends on the concentrations of 
biosynthesis enzymes. For example, in the Solanum lycopersicum peel, the level of CHS and 
flavanone 3-hydroxylase gene expression is higher than the CHI, indicating the accumulation of 
high amount of naringenin chalcone (Iijima, Suda, Suzuki, Aoki, & Shibata, 2008). Isolation of 
naringenin from natural sources for biological research and commercial applications is 
insufficient and has been engaged with various difficulties, such as low yield value, expensive 
isolation method, time-consuming processing, seasonal availability, and region-specific 
availability, etc. For example, Luengo and team (2013) applied pulsed-electric field treatment for 
extraction of polyphenol from orange peel. Even though their approaches improved the 
production of naringenin from 1 to 3.1 mg/100 g of fresh orange peels (Luengo, Álvarez, & 
Raso, 2013), the yield still shows limited output, when it is compared with microbial-assisted 
production of naringenin (overall yield approximately 474.2 mg/L) (Xu, Ranganathan, Fowler, 
Maranas, & Koffas, 2011). On the other hand, naringenin can be synthesized through a chemical 
process. Acylation of 1,3,5-trimethoxybenzene with p-methoxycinnamic acid yielded 29% 
naringenin (Wang et al., 2015). The alternative method used in the same study exhibited the 
naringenin yield is of 45–60%. The process includes the conversion of 3,5-dimethoxyphenol into 
2-hydroxy-4,6-dimethoxyacetophenone followed by condensation with anisaldehyde to produce 
2′-hydroxy-4,4′,6′-trimethoxychalcone. This chalcone is then cyclized and demethylated with 
aqueous HCl and pyridine hydrochloride to form naringenin (overall yield 45%). Also, 
condensation of 2-hydroxy-4,6-dimethoxyacetophenone with anisaldehyde can produce 4′,5,7-
trimethoxyflavanone, which was then converted into naringenin with 60% yield (Wang et al., 
2015). However, these approaches are troubled with high-cost, complex reaction cascades, toxic 
chemicals, and complex purification processes. As a result, alternative routes leading to 
naringenin e.g., microbial biosynthesis are important to maximize the production rate, minimize 
the cost and time, and to improve product safety as well as quality (Xie, Su, Sun, Zheng, & 
Chen, 2018). This is because microorganisms and plants share a similar primary metabolism 
whereas the microorganisms naturally produce the precursors, such as phenylalanine, tyrosine, 
malonyl-CoA, etc. These precursor molecules are required to produce naringenin as well as other 
polyphenols using microorganism platforms. For this reason, various strain and process 
development for microbial naringenin production has become a recent interesting and attractive 
challenge in metabolic engineering (Milke, Aschenbrenner, Marienhagen, & Kallscheuer, 2018). 
 
 
Fig. 4. Schematic overview of naringenin against metabolic diseases. 
 
11. Overview and future directions 
 
The monotherapy of conventional drug is a challenge to treat various diseases related to 
metabolic syndrome. Clinical trial study of Vit-E treatment indicated an increase in the incidence 
of cardiac failure (Investigators, 1999; Lonn et al., 2005). In addition, Vit-C and -E treatments 
exerted cardiovascular side-effects (Sesso et al., 2008). These limitations of well-known 
antioxidant molecules create the new possibilities for investigating other bioactive compounds 
for the treatment of metabolic diseases. The studies discussed in this review showed that 
naringenin exhibited the potential antioxidant, antihyperlipidemic, anti-obesity, anti-
hyperglycemic, anti-diabetic, anti-inflammatory, anti-hypertensive, cardioprotective, 
hepatoprotective, renoprotective, and neuroprotective activities (Fig. 4). Dietary naringenin and 
its derivatives exert effects by targeting various cellular signaling pathways including its 
antioxidant activity by scavenging free radicals, inducing antioxidant enzymes and targeting on 
PI3K/Akt/Nrf2, NRf2/ARE, NF-kB, MAPK, HMG-CoA reductase, PPAR and NO-cGMP-PKG-
KATP channels. It is important to note that most of the studies have been conducted in either cell 
type models or animal models (rat and mice). Therefore, further clinical study and trial are 
required to illustrate the protective effects of naringenin against metabolic syndromes in human. 
However, such studies should consider the appropriate doses to be used to achieve its protective 
effects. People may increase the citrus fruit consumption as a source of dietary supplement since 
naringenin is mostly obtained from the citrus fruit. 
 
Due to low yield value, time-consuming extraction, and the high cost of purification steps, the 
alternative process of naringenin production is needed. Consecutive research on naringenin 
biosynthesis in Saccharomyces cerevisiae, Streptomyces clavuligerus, and E. coli reported 
production of pure naringenin with high yields from glucose (Milke et al., 2018). In conclusion, 
naringenin may be a suitable alternative agent for the treatment of metabolic syndromes (Fig. 4), 
and its production in microorganism is one of the suitable alternative methods for achieving 
high-yield. 
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